Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stroke | Behavioral: 3D Behavioral: 1D | Not Applicable |
Currently can't recruit due to COVID-19
Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke.
Stroke survivors with moderate to severe hand impairment with at least palpable volitional grip force will randomly be assigned to either the experimental or control group, stratified by impairment level. Both groups will undergo 3 1-hr training sessions per week for 6 weeks in which they practice volitional finger force generation against force sensors. The experimental group will practice for various target force directions to explore the 3D force workspace and receive feedback in 3D force, while the control group will practice 1D force generation without feedback on other directional forces on a computer screen.
Training will progress by increasing influence of flexion synergy by varying posture requirements and increasing force level, introducing feedback delay, and incorporating unilateral/bilateral activity. Evaluation will occur at baseline (3 times over 3 weeks to establish baseline trends) and every 2 weeks during 6-week intervention to determine pattern of progress, and at 1-month follow-up to assess retention.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke |
Actual Study Start Date : | October 28, 2020 |
Estimated Primary Completion Date : | October 31, 2023 |
Estimated Study Completion Date : | October 31, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: 3D
The participant's voluntary grip forces in all 3 dimensions will be shown to the participant via computer screen.
|
Behavioral: 3D
Practice generating grip force to the target shown on the computer screen in 3 dimensions.
|
Active Comparator: 1D
The participant's voluntary grip force in 1 dimension will be shown to the participant via computer screen.
|
Behavioral: 1D
Practice generating grip force to the target shown on the computer screen in 1 dimension.
|
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Na Jin Seo, PhD MS BS | (843) 792-0084 | seon@musc.edu |
United States, South Carolina | |
Ralph H. Johnson VA Medical Center, Charleston, SC | Recruiting |
Charleston, South Carolina, United States, 29401-5799 | |
Contact: Rutha A LaRue 843-789-6707 Rutha.Larue@va.gov | |
Contact: Sarah A Jackson, BA MA (843) 789-6700 sarah.jackson@va.gov | |
Principal Investigator: Na Jin Seo, PhD MS BS |
Principal Investigator: | Na Jin Seo, PhD MS BS | Ralph H. Johnson VA Medical Center, Charleston, SC |
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | June 19, 2019 | ||||||||
First Posted Date ICMJE | June 21, 2019 | ||||||||
Last Update Posted Date | April 14, 2021 | ||||||||
Actual Study Start Date ICMJE | October 28, 2020 | ||||||||
Estimated Primary Completion Date | October 31, 2023 (Final data collection date for primary outcome measure) | ||||||||
Current Primary Outcome Measures ICMJE |
Action Research Arm Test (ARAT) [ Time Frame: 3rd baseline to within 1 week post intervention ] a clinical assessment for upper extremity function
|
||||||||
Original Primary Outcome Measures ICMJE | Same as current | ||||||||
Change History | |||||||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||
Current Other Pre-specified Outcome Measures |
|
||||||||
Original Other Pre-specified Outcome Measures | Same as current | ||||||||
Descriptive Information | |||||||||
Brief Title ICMJE | Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke | ||||||||
Official Title ICMJE | Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke | ||||||||
Brief Summary | Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke. | ||||||||
Detailed Description |
Currently can't recruit due to COVID-19 Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke. Stroke survivors with moderate to severe hand impairment with at least palpable volitional grip force will randomly be assigned to either the experimental or control group, stratified by impairment level. Both groups will undergo 3 1-hr training sessions per week for 6 weeks in which they practice volitional finger force generation against force sensors. The experimental group will practice for various target force directions to explore the 3D force workspace and receive feedback in 3D force, while the control group will practice 1D force generation without feedback on other directional forces on a computer screen. Training will progress by increasing influence of flexion synergy by varying posture requirements and increasing force level, introducing feedback delay, and incorporating unilateral/bilateral activity. Evaluation will occur at baseline (3 times over 3 weeks to establish baseline trends) and every 2 weeks during 6-week intervention to determine pattern of progress, and at 1-month follow-up to assess retention. |
||||||||
Study Type ICMJE | Interventional | ||||||||
Study Phase ICMJE | Not Applicable | ||||||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Outcomes Assessor) Primary Purpose: Treatment |
||||||||
Condition ICMJE | Stroke | ||||||||
Intervention ICMJE |
|
||||||||
Study Arms ICMJE |
|
||||||||
Publications * | Not Provided | ||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status ICMJE | Recruiting | ||||||||
Estimated Enrollment ICMJE |
60 | ||||||||
Original Estimated Enrollment ICMJE | Same as current | ||||||||
Estimated Study Completion Date ICMJE | October 31, 2023 | ||||||||
Estimated Primary Completion Date | October 31, 2023 (Final data collection date for primary outcome measure) | ||||||||
Eligibility Criteria ICMJE |
Inclusion Criteria:
Exclusion Criteria:
|
||||||||
Sex/Gender ICMJE |
|
||||||||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | ||||||||
Accepts Healthy Volunteers ICMJE | No | ||||||||
Contacts ICMJE |
|
||||||||
Listed Location Countries ICMJE | United States | ||||||||
Removed Location Countries | |||||||||
Administrative Information | |||||||||
NCT Number ICMJE | NCT03995069 | ||||||||
Other Study ID Numbers ICMJE | A3066-R | ||||||||
Has Data Monitoring Committee | Yes | ||||||||
U.S. FDA-regulated Product |
|
||||||||
IPD Sharing Statement ICMJE |
|
||||||||
Responsible Party | VA Office of Research and Development | ||||||||
Study Sponsor ICMJE | VA Office of Research and Development | ||||||||
Collaborators ICMJE | Not Provided | ||||||||
Investigators ICMJE |
|
||||||||
PRS Account | VA Office of Research and Development | ||||||||
Verification Date | April 2021 | ||||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |